drugset / Trial / NCT01935167
To Determine the Efficacy and Safety of DW1029M on Microalbuminuria in Patients With Diabetic Nephropathy
RandomizedParallel-groupDouble-blindTreatment
Summary
Phase 2 clinical study to evaluate of the efficacy and safety of DW1029M on microalbuminuria in Patients With Diabetic Nephropathy
Timeline
- Start
- 2013-10
- Primary completion
- 2014-08
- Completion
- 2015-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DW1029M | Unknown | 600 mg | — |
| Subject | DW1029M | Unknown | 1200 mg | — |